Exhibit 10.2
CORTEXYME, INC.
February 1, 2022
Stephen S. Dominy, M.D. VIA EMAIL
Dear Steve:
This letter sets forth the substance of the separation agreement (the “Agreement”) that Cortexyme, Inc. (the “Company”) is offering to you to aid in your employment transition.
263438815 v2
Page 2
263438815 v2
Page 3
263438815 v2
Page 4
263438815 v2
Page 5
“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.”
You hereby expressly waive and relinquish all rights and benefits under that section and any law of any other jurisdiction of similar effect with respect to your release of claims herein, including but not limited to your release of unknown claims.
263438815 v2
Page 6
263438815 v2
Page 7
If this Agreement is acceptable to you, please sign below and return the original to me. You have forty-five (45) calendar days to decide whether to accept this Agreement, and the Company’s offer contained herein will automatically expire if you do not sign and return it within that timeframe.
263438815 v2
Page 8
We wish you the best in your future endeavors.
Sincerely,
By: |
| /s/ Christopher Lowe |
|
| Chris Lowe |
|
| COO & CFO |
I HAVE READ, UNDERSTAND AND AGREE FULLY TO THE FOREGOING AGREEMENT:
| /s/ Stephen S. Dominy, M.D. |
| Stephen S. Dominy, M.D. |
| Date: February 2, 2022 |
|
|
263438815 v2